Valneva stock Lyme vaccine

NEUTRAL by u/NailHistorical9431 | Jul 06, 2026 | 1↑ 0 comments | 22 views | VIEW ON REDDIT

$VALN

$VALN VALNEVA SE HEALTHCARE EQUITY SIMULATION

$5.22

+0.13 (+2.65%)

LAST PRICE · 15 MIN DELAY

DAY CHG +2.65%

5D CHG +0.29%

30D CHG -10.99%

AI SUMMARY — Valneva is developing a Lyme disease vaccine candidate with potential market opportunity as Lyme disease cases continue to rise. Key risks include regulatory approval uncertainty, competition from other vaccine developers, and clinical trial outcomes.

TICKER	VALN	USER	u/NailHistorical9431
RATING	NEUTRAL	ENTRY	$5.24
POSITION	1913 sh SYN	BOOK VAL	$10024.12
CURRENT	$5.22	P&L %	-0.29%
CURR VAL	$9995.42	P&L $	-28.70